Molecular Partners AG reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was CHF 3.05 million compared to CHF 172.78 million a year ago. Net loss was CHF 14.78 million compared to net income of CHF 153.13 million a year ago.

Basic loss per share from continuing operations was CHF 0.45 compared to basic earnings per share from continuing operations of CHF 4.74 a year ago. Diluted loss per share from continuing operations was CHF 0.45 compared to diluted earnings per share from continuing operations of CHF 4.62 a year ago.